BioLife Solutions (FRA:BJX1) Total Stockholders Equity : €333.21 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is BioLife Solutions Total Stockholders Equity?

BioLife Solutions's Total Stockholders Equity for the quarter that ended in Dec. 2024 was €333.21 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. BioLife Solutions's Book Value per Share for the quarter that ended in Dec. 2024 was €7.10. The ratio of a company's debt over equity can be used to measure how leveraged this company is. BioLife Solutions's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.09.

BioLife Solutions Total Stockholders Equity Historical Data

The historical data trend for BioLife Solutions's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLife Solutions Total Stockholders Equity Chart

BioLife Solutions Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

168.71

423.07

343.79

309.64

333.21

BioLife Solutions Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial															309.64	306.73	298.62	293.24	333.21

BioLife Solutions (FRA:BJX1) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

BioLife Solutions's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(333.208	-	0)	/	46.907
	=	7.10

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

BioLife Solutions's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(11.894	+	16.923)	/	333.208
	=	0.09

BioLife Solutions Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of BioLife Solutions's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLife Solutions Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioLife Solutions Inc (FRA:BJX1) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

BLFS:USA BJX1:Germany

Address

3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021

Website

https://www.biolifesolutions.com

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

BioLife Solutions Headlines

No Headlines